This ad is being circulated again, and sending a lot of questions our way, so I’m re-posting our solution (which first appeared on September 4, 2019) and taking an updated look — the ad itself has not been updated at all, as far as I can tell, but I’ll add my updated thoughts throughout and […]
Articles
Almost as soon as I posted my update to our teaser solution about Stephen Leeb’s big copper pitch last week, the questions started coming in about his other mining ad that’s been popping up with gold’s rise — the ad is for The Complete Investor, his entry-level newsletter over at Investing Daily ($39/yr), and the […]
The steady thirst for 5G fortunes is far from being slaked, it appears — pretty much all publishers have some tried some kind of promotion to convince us that they have the best and most lucrative idea for investing in the next upgrade cycle in mobile telecom… and today we’re looking at the latest spiel […]
Scott Chan is pretty new to the world of newsletter pitchmen, but he’s apparently been working for Investing Daily for a while as a technology analyst, and is now headlining his second ad for them (that I’ve seen, at least). The last one was pitching a stem cell immunotherapy biotech stock (which hasn’t worked so […]
Dr. Stephen Leeb is jumping on the rare earths bandwagon, already crowded with newsletter pundits of every stripe, and promising that these “more precious than gold” elements will “outperform the hottest stocks.” The argument is a fairly basic one, and we’ve heard it many times: China controls most of the world’s supply of rare earth […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Hi, I started following KSS here, and moved over to BioPub as well. I have substantial positions in over a dozen of his...
Oncolytics Biotech® Announces Presentation at the Society for Immunotherapy of Cancer 2018 Annual Meeting Showcasing Up...
Wow, very encouraging data for oncolytic H-1 parvovirus + avastin + PD1 combo in #Glioblastoma at #SNO18 78% ORR: 22% C...
$ONCY Dr. Annels, et al., will present pelareorep data at #SITC2018 showcasing upregulation of PD-L1 expression with reo...
Oncolytics Biotech® Announces Abstract for ASH Annual Meeting & Exposition Demonstrating Pelareorep Increases PD-L1 Exp...
$ONCY > OV's have shown an ability to turn cold tumors hot. We believe pelareorep will in mBC and excited to start work...
Pvt company: StemImmune. Vaccinia as oncolytic virus play. To cut to the chase, this company is too tentative and specul...